Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Cardiol ; 82(6): 455-459, 2023 12.
Artículo en Inglés | MEDLINE | ID: mdl-37459964

RESUMEN

BACKGROUND: n-3 polyunsaturated fatty acids (PUFAs) reduce the risk of ischemic heart disease. However, there are few reports of a relationship between n-3 PUFAs and coronary spastic angina (CSA). This study aimed to assess the age-dependent role of serum levels of fatty acid in patients with CSA. METHODS AND RESULTS: We enrolled 406 patients who underwent ergonovine tolerance test (ETT) during coronary angiography for evaluation of CSA. All ETT-positive subjects were diagnosed as having CSA. We categorized the patients by age and results of ETT as follows: (1) young (age ≤ 65 years) CSA-positive (n = 32), (2) young CSA-negative (n = 134), (3) elderly (age > 66 years) CSA-positive (n = 36), and (4) elderly CSA-negative (n = 204) groups. We evaluated the serum levels of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), arachidonic acid, and dihomo-gamma-linolenic acid. In the young groups, the serum levels of EPA (64.3 ±â€¯37.7 µg/mL vs. 49.4 ±â€¯28.8 µg/mL, p = 0.015) and DHA (135.7 ±â€¯47.6 µg/mL vs. 117.4 ±â€¯37.6 µg/mL, p = 0.020) were significantly higher in the CSA-positive group than in the CSA-negative group, respectively. However, this was not the case with elderly groups. In the multivariate analysis in young groups, the serum levels of EPA (p = 0.028) and DHA (p = 0.049) were independently associated with the presence of CSA, respectively. CONCLUSION: Our results suggested that the higher serum levels of EPA and/or DHA might be involved in the pathophysiology of CSA in the young population but not in the elderly population.


Asunto(s)
Angina de Pecho , Vasoespasmo Coronario , Pueblos del Este de Asia , Ácidos Grasos Insaturados , Anciano , Humanos , Ácidos Docosahexaenoicos/sangre , Ácido Eicosapentaenoico/sangre , Ácidos Grasos , Ácidos Grasos Omega-3/sangre , Ácidos Grasos Insaturados/sangre , Angina de Pecho/etiología , Vasoespasmo Coronario/sangre , Vasoespasmo Coronario/inducido químicamente , Vasoespasmo Coronario/diagnóstico por imagen , Factores de Edad , Ergonovina/efectos adversos , Vasoconstrictores/efectos adversos , Angiografía Coronaria , Persona de Mediana Edad
2.
Fiziol Zh (1994) ; 40(3-4): 81-7, 1994.
Artículo en Ucraniano | MEDLINE | ID: mdl-7621960

RESUMEN

The effect of phosphocreatine and hydroxamate-linoleate (an inhibitor of lipoxigenase) on development of the pathologic process in coronary vessels with immune (cytotoxic) injury of the heart was studied in the experiments on narcotized dogs. Development of the immune response after administration of cardiac serum resulted in development of large transmural damage of the left ventricle myocardium, increased resistance of coronary vessels and changed coronary vascular reactions, which correlates with changes in arachidonic acid metabolism. Experimental data described in this report demonstrate the efficiency of membrane coronary vessels stabilization and inhibition of a lipoxygenase pathway in arachidonic acid metabolism in protection of immune damage of the heart and coronary vessels.


Asunto(s)
Ácido Araquidónico/sangre , Vasoespasmo Coronario/sangre , Animales , Vasoespasmo Coronario/tratamiento farmacológico , Vasoespasmo Coronario/etiología , Vasoespasmo Coronario/inmunología , Modelos Animales de Enfermedad , Perros , Evaluación Preclínica de Medicamentos , Sueros Inmunes , Leucotrieno C4/sangre , Ácidos Linoleicos/uso terapéutico , Lipooxigenasa/sangre , Lipooxigenasa/efectos de los fármacos , Inhibidores de la Lipooxigenasa/uso terapéutico , Miocardio/inmunología , Fosfocreatina/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA